If you liked this article you might like

Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
Celgene Second-Quarter Earnings Yield No Surprises, Small Guidance Bump
Biomarin Hemophilia Gene Therapy Advances on Strong Study Results
Anavex Alzheimer's Drug Plays Losing Game Against Placebo Effect